Breast magnetic resonance imaging for estimation of the tumour extent in patients with pure ductal carcinoma in situ: Comparison between full diagnostic and abbreviated protocols

被引:11
|
作者
Shiraishi, Megumi [1 ]
Igarashi, Takao [1 ]
Terayama, Tomomi [1 ]
Watanabe, Ken [1 ]
Ashida, Hirokazu [1 ]
Ojiri, Hiroya [1 ]
机构
[1] Jikei Univ, Dept Radiol, Sch Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan
关键词
Breast; Ductal carcinoma in situ; Magnetic resonance imaging; MRI; MAMMOGRAPHY; CANCER; ENHANCEMENT; ACCURACY; REVEALS; PATTERN; LESIONS; US;
D O I
10.1016/j.ejrad.2019.108788
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the rate of concordance between pathology and preoperative breast MRI performed with an abbreviated protocol (AP) or a full diagnostic protocol (FDP) for estimation of the tumour extent in patients with pure ductal carcinoma in situ (DCIS). Methods: This retrospective study included 164 patients with pathologically proven DCIS who underwent preoperative breast MRI. Two radiologists independently evaluated the tumour extent on MRI with (FDP) and without the delayed phase (AP) and compared the readings with the pathological tumour extent. The background parenchymal enhancement (BPE) and morphology were also evaluated. Furthermore, the influence of the degree of BPE, presence or absence of B2 and B3 lesions, and pathological DCIS grade on the accuracy of MRI findings was assessed. Concordance between MRI and pathology was evaluated using correlation analysis. Results: Spearman's rank correlation coefficients for the concordance between MRI and pathology were 0.63 (reader 1) and 0.69 (reader 2) with AP and 0.65 and 0.73 (readers 1 and 2, respectively) with FDP. For both readers, the difference in the measured value between FDP and pathology was significantly smaller than that between AP and pathology (p < 0.001). The inter-reader variation in the measured tumour extent was larger with FDP than with AP. The presence of B3 lesions, low-grade DCIS, and moderate/marked BPE lowered the rate of concordance between MRI and pathology. Conclusions: Our findings suggest that preoperative MRI with FDP is more accurate than that with AP alone for estimation of the tumour extent in patients with pure DCIS.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Accurate Estimation of Breast Tumor Size: A Comparison Between Ultrasonography, Mammography, Magnetic Resonance Imaging, and Associated Contributing Factors
    Azhdeh, Shilan
    Kaviani, Ahmad
    Sadighi, Nahid
    Rahmani, Maryam
    EUROPEAN JOURNAL OF BREAST HEALTH, 2021, 17 (01) : 53 - 61
  • [22] Diagnostic performance of digital breast tomosynthesis for predicting response to neoadjuvant systemic therapy in breast cancer patients: A comparison with magnetic resonance imaging, ultrasound, and full-field digital mammography
    Murakami, Ryusuke
    Tani, Hitomi
    Kumita, Shinichiro
    Uchiyama, Nachiko
    ACTA RADIOLOGICA OPEN, 2021, 10 (12)
  • [23] Preoperative prediction of the size of pure ductal carcinoma in situ using three imaging modalities as compared to histopathological size: does magnetic resonance imaging add value?
    Daniel, Ojuka Kinyuru
    Lim, Sung Mook
    Kim, Joo Heung
    Park, Hyung Seok
    Park, Seho
    Kim, Seung Il
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (02) : 437 - 444
  • [24] The influence of clinicopathological features on the predictive accuracy of conventional breast imaging in determining the extent of screen-detected high-grade pure ductal carcinoma in situ
    Hayward, L.
    Oeppen, R. S.
    Grima, A. V.
    Royle, G. T.
    Rubin, C. M.
    Cutress, R. I.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2011, 93 (05) : 385 - 390
  • [25] Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment
    Lehman, Constance D.
    Gatsonis, Constantine
    Romanoff, Justin
    Khan, Seema A.
    Carlos, Ruth
    Solin, Lawrence J.
    Badve, Sunil
    McCaskill-Stevens, Worta
    Corsetti, Ralph L.
    Rahbar, Habib
    Spell, Derrick W.
    Blankstein, Kenneth B.
    Han, Linda K.
    Sabol, Jennifer L.
    Bumberry, John R.
    Gareen, Ilana
    Snyder, Bradley S.
    Wagner, Lynne, I
    Miller, Kathy D.
    Sparano, Joseph A.
    Comstock, Christopher
    JAMA ONCOLOGY, 2019, 5 (07) : 1036 - 1042
  • [26] Magnetic Resonance Mammography of Invasive Lobular Versus Ductal Carcinoma: Systematic Comparison of 811 Patients Reveals High Diagnostic Accuracy Irrespective of Typing
    Dietzel, Matthias
    Baltzer, Pascal A.
    Vag, Tibor
    Groeschel, Tobias
    Gajda, Mieczyslaw
    Camara, Oumar
    Kaiser, Werner A.
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2010, 34 (04) : 587 - 595
  • [27] No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy
    Vapiwala, Neha
    Hwang, Wei-Ting
    Kushner, Carolyn J.
    Schnall, Mitchell D.
    Freedman, Gary M.
    Solin, Lawrence J.
    CANCER, 2017, 123 (08) : 1324 - 1332
  • [28] ACCURACY OF AN AUTOMATED BREAST VOLUME ULTRASOUND SYSTEM FOR ASSESSMENT OF THE PRE-OPERATIVE EXTENT OF PURE DUCTAL CARCINOMA IN SITU: COMPARISON WITH A CONVENTIONAL HANDHELD ULTRASOUND EXAMINATION
    Li, Na
    Jiang, Yu-Xin
    Zhu, Qing-Li
    Zhang, Jing
    Dai, Qing
    Liu, He
    Yang, Qian
    Wang, Hong-Yan
    Lai, Xing-Jian
    Sun, Qiang
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2013, 39 (12) : 2255 - 2263
  • [29] Magnetic Resonance Imaging in Patients Diagnosed With Ductal Carcinoma-In-Situ: Value in the Diagnosis of Residual Disease, Occult Invasion, and Multicentricity
    E. Shelley Hwang
    Karen Kinkel
    Laura J. Esserman
    Ying Lu
    Noel Weidner
    Nola M. Hylton
    Annals of Surgical Oncology, 2003, 10 : 381 - 388
  • [30] Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: Value in the diagnosis of residual disease, occult invasion, and multicentricity
    Hwang, EW
    Kinkel, K
    Esserman, LJ
    Lu, Y
    Weidner, N
    Hylton, NM
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (04) : 381 - 388